Abstract

Radioisotopes that emit electrons (beta particles), such as radioiodine, can effectively kill target cells, including cancer cells. Aqueous 32P[PO4] is a pure beta-emitter that has been used for several decades to treat non-malignant human myeloproliferative diseases. 32P[PO4] was directly compared to a more powerful pure beta-emitter, the clinically important 90Y isotope. In vitro, 32P[PO4] was more effective at killing cells than was the more powerful isotope 90Y (P ≤ 0.001) and also caused substantially more double-stranded DNA breaks than did 90Y. In vivo, a single low-dose intravenous dose of aqueous elemental 32P significantly inhibited tumor growth in the syngeneic murine cancer model (P ≤ 0.001). This effect is exerted by direct incorporation into nascent DNA chains, resulting in double-stranded breakage, a unique mechanism not duplicatable by other, more powerful electron-emitting radioisotopes. 32P[PO4] should be considered for human clinical trials as a potential novel anti-cancer drug.

Highlights

  • Beta particles emitted by radioisotopes are known to efficiently kill cancer cells

  • Beta particle-emitting radiolabeled antibodies directed against CD20, including 131I-Bexxar and 90Y-Zevalin, have been used against non-Hodgkin’s lymphoma [2,3]

  • The resulting bystander effect amplifies the lethal potential of each beta particle emitted in or near a tumor

Read more

Summary

Introduction

Beta particles (electrons) emitted by radioisotopes are known to efficiently kill cancer cells. This finding has already been clinically exploited by using 131I to treat thyroid cancer [1], a strategy still employed successfully in more than 50% of such patients in the United States, with over a 90% cure rate. 90Y-labeled somatostatin receptor ligand is utilized to treat neuroendocrine tumors [4]. Electrons emitted by 32P have an energy level intermediate between those of 131I and the more powerful 90Y, resulting in a path length of up to 5 mm in human tissues [5]. Electrons emitted from radioisotopes can strike thousands of cells. The resulting bystander effect amplifies the lethal potential of each beta particle emitted in or near a tumor.

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.